以融合蛋白形式在大肠杆菌中表达人MCP—1

将编码人单核细胞趋化蛋白－１（ＭＣＰ－１）的基因亚克隆到大肠杆菌表达载体ｐＥＸ３１Ａ中,在大肠杆菌中表达出ＭＳ２／ＭＣＰ－１融合蛋白,该表达产物约占菌体总蛋白的１５％左右,Ｗｅｓｔｅｒｎ ｂｌｏｔ检测表明,表达产物可与ＭＣＰ－１抗体特异反应,采用琼脂糖平板法进行活性测定表明,表达产物具有明显的单核细胞趋化活性,说明Ｎ端融合一段细菌蛋白对ＭＣＰ－１有无趋化活性可能没有影响。     

在大肠杆菌中表达人防御素—1

构建了一组ＨＮＰ－１原核表达载体,其中有几个含ＳＤ或Ω序列的载体,在表达产物中检测到了ＨＮＰ－１的存在,说明宿主菌是否在任何情况下都降解外源小分子多肽是一个值得考虑的问题,另外,从表达载体在大肠杆菌ＪＭ１０９和ＪＭ１０９（ＤＥ３）中蛋白表达量的差异也可推测ＨＮＰ－１发生了低水平的表达,ＨＮＰ－１对细菌的作用与ＨＮＰ－１浓度和细菌本身的生理状况密切相关。     

在大肠杆菌中表达人防御素-1

构建了一组HNP-1原核表达载体,其中有几个含SD或序列的载体,在表达产物中检测到了HNP-1的存在,说明宿主菌是否在任何情况下都降解外源小分子多肽是一个值得考虑的问题．另外从表达载体在大肠杆菌JM109和JM109（DE3）中蛋白表达量的差异也可推测HNP-1发生了低水平的表达,HNP-1对细菌的作用与HNP-1浓度和细菌本身的生理状况密切相关.     

PPF1基因C端片段在大肠杆菌中的融合表达和纯化以及抗体制备

PPF1是与G2豌豆短日不衰老现象紧密相关的基因之一 .以pSK PPF1为模板 ,用PCR方法得到了编码该蛋白C端的基因片段 ,称为PPFC .进一步将该基因片段克隆到中间载体pGEM T easy ,再酶切得到PPFC片段插入到pGEX 4T 1载体中 ,构建成表达质粒pGEX 4T PPFC .在BL2 1细胞中经IPTG诱导表达 ,得到GST PPFC融合蛋白 .用GST亲和柱纯化得到PPFC蛋白 ,将其作为抗原得到兔源的多克隆抗体 .Western杂交分析表明所得到的抗体具有较强的特异性 ,ELISA分析证实其效价为 10 6.该抗体的获得为用免疫沉淀等免疫分析技术研究PPF1与其它蛋白质的相互作用 ,从而阐明PPF1在延缓G2豌豆衰老中的分子机制提供了可能     

HIV-1融合蛋白MA4-CA在大肠杆菌中的高效表达

将HIV-1MA4-CA融合基因克隆到高效表达载体pBV220中,将该重组表达载体转化大肠杆菌BL21,进行诱导表达。收集细菌,菌体裂解后进行SDS—PAGE检测。结果表明,成功地构建了含MA4-CA融合基因的表达载体pBV220-MA4-CA,该载体能在大肠杆菌中表达相对分子质量为16000并以包涵体形式存在的融合蛋白,此蛋白经洗涤后能够溶于8mol／L的尿素中。利用硫酸铵沉淀法进行初步纯化后即可得到纯度比较高的MA4-CA融合蛋白,为今后进一步的功能和应用研究打下了良好的基础。     

人胸腺素α1基因在毕赤酵母中的融合表达

根据已知人胸腺素1（human Thymosin α1,hTα1）的氨基酸序列和毕赤酵母偏爱密码子,人工合成了hTα1基因。用合成的hTα1基因取代核糖体蛋白（ribosomal protein,RP）基因5′端的84个碱基,组成重组基因hTα1-RP,连接到质粒pPIC3.5K上,构建表达质粒pPIC3.5K/hTα1-RP。表达质粒用电激法转化到毕赤酵母GS115菌株中。甲醇诱导表达融合蛋白,SDS-PAGE和Western印迹结果证明,重组基因hTα1-RP在酵母中得到了表达,表达量约为25mg/L。Construction and Expression of Recombinant Human Thymosin α1 Fusion Gene in Pichia pastoris HUANG Wen,LI Zhao-yu,JIN Li-ji,AN Li-jiaAbstract:The human Thymosin α1 (hTα1) gene was synthesized according to the optimal codons of Pichia pastoris and was fused in 5' terminal of ribosomal protein (RP) gene using over lapping polymerase chain reaction.The fusion gene was inserted into expression vector of pPIC3.5K and was transformed into HIS4 mutant strain GS115 by electroporation.Both SDS-PAGE and Western blot indicated that this fusion protein was expressed.The expression level was about 25mg/L.Key words：human Thymosin α1; fusion protein; Pichia pastoris     

rhGM—CSF／LIF融合蛋白基因的克隆及表达

利用基因重组技术,人工构建了一个编码五肽Ｇ－Ｓ－Ｇ－Ｇ－Ｓ的基因接头,将ＧＭ－ＣＳＦ和ＬＩＦ的ｃＤＮＡ相连而构成融合基因,将融合基因载入原核表达载体ｐＢＶ２２０后转化大肠杆菌,经热诱导后进行Ｗｅｓｔｅｒｎ印迹反应鉴定证实获得ｒｈＧＭ－ＣＳＦ／ＬＩＦ融合蛋白（简称ｒｈｇＭ－ＬＩＦ）活性测定表明重组的融合蛋白具有两因子双重活性。     

EGF-SEA融合蛋白在大肠杆菌中的表达和纯化

根据基因库中查到的金黄色葡萄球菌肠毒素A(SEA)基因序列和人体表皮生长因子(EGF)基因序列进行密码子优化,以适于大肠杆菌表达.人工合成SEA基因与EGF基因.将两目的基因克隆至原核表达栽体pFT22b中,经测序验证表明成功构建了重组表达质粒pET22b-EGF-SEA.将构建好的pET22b-EGF-SEA质粒转化大肠杆菌BL21(DE3),经IPTG诱导进行表达;SDS-PAGE分析表明融合基因EGF-SEA在大肠杆菌BL21(DE3)中以包涵体的形式得到了高效表达,产物相对分子质量约为44kDa,与理论值大小一致.包涵体经洗涤,变性、复性后用His Bind Kit进行分离纯化,所得蛋白纯度≥95%.高纯度EGF-SEA融合蛋白的获得为进一步研究其生物学活性及肿瘤治疗奠定了基础.     

VEGF受体Flt—1在大肠杆菌中的高效融合表达

鉴于Ｆｌｔ－１有肿瘤及其他由于病理血管生成而导致的多种疾病中的核心作用,本文通过ＰＣＲ扩增出的ＶＥＧＦ受体Ｆｌｔ－１Ｎ端１－３个ＩｇＧ样ｌｏｏｐ基因,经过基因重组实现了Ｆｌｔ－１在原核表达体系５Ｘ－１的融合表达。     

辛伐他汀干预鼠颈动脉损伤MCP-1的表达

应用鼠颈动脉结扎模型,采用原位杂交、免疫组化技术观察血管单核细胞趋化蛋白-1(monocyte chemoattractant protein-1, MCP-1)的表达及内膜增生情况,探讨辛伐他汀抗内膜增生机制.结果发现损伤血管内膜增生明显,MCP-1的表达增加;辛伐他汀干预可明显抑制血管MCP-1的表达及新生内膜形成.提示血管内膜增生可能与MCP-1表达上调有关,辛伐他汀抑制内膜增生也许通过MCP-1介导.     

单核细胞趋化蛋白-1与2型糖尿病大血管病变

单核细胞趋化蛋白-1(monocyte chemoattractant protein-1;MCP-1)属于炎症趋化因子CC亚族成员,它能趋化T淋巴细胞、单核细胞,诱导内皮细胞、单核细胞释放黏附因子,使单核/巨噬细胞向病变处聚集。这些免疫及炎症过程有可能导致2型糖尿病大血管病变的发生、发展。本文就单核细胞趋化蛋白-1促使动脉粥样硬化的机制、及其干预治疗,单核细胞趋化蛋白-1表达上调的影响因素,深入了解单核细胞趋化蛋白-1与2型糖尿病大血管病变的关系。     

Visualization of chemokine binding sites on human brain microvessels

The chemokines monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1alpha (MIP-1alpha) aid in directing leukocytes to specific locales within the brain and spinal cord during central nervous system inflammation. However, it remains unclear how these chemokines exert their actions across a vascular barrier, raising speculation that interaction with endothelial cells might be required. Therefore, experiments were performed to determine whether binding domains for these chemokines exist along the outer surface of brain microvessels, a feature that could potentially relay chemokine signals from brain to blood. Using a biotinylated chemokine binding assay with confocal microscopy and three-dimensional image reconstruction, spatially resolved binding sites for MCP-1 and MIP-alpha around human brain microvessels were revealed for the first time. Binding of labeled MCP-1 and MIP-1alpha could be inhibited by unlabeled homologous but not heterologous chemokine, and was independent of the presence of heparan sulfate, laminin, or collagen in the subendothelial matrix. This is the first evidence of specific and separate binding domains for MCP-1 and MIP-1alpha on the parenchymal surface of microvessels, and highlights the prospect that specific interactions of chemokines with microvascular elements influence the extent and course of central nervous system inflammation.     

Interplay of CCR2 signaling and local shear force determines vein graft neointimal hyperplasia in vivo

Leukocytes play a central role in vein graft neointimal hyperplasia, which is significantly augmented under low shear conditions. The current concept is that shear force regulates leukocyte adhesion predominately through up-regulation of chemokines and growth factors within the graft wall. Using rabbit and murine vein graft models, we demonstrate that CC chemokine receptor 2/monocyte chemoattractant protein-1 mediated monocyte recruitment and a low shear environment act synergistically to augment neointimal hyperplasia development and removal of either of the conditions leads to a significant reduction in neointimal thickening. We propose a novel concept that the shear stress response element phenotypically stems from the complex interplay of the biological and physical microenvironments.     

单核细胞趋化蛋白-1在糖尿病肾病中的作用

糖尿病肾病是多因素引起的复杂性疾病,近年研究发现炎症反应参与了该病的发生与发展.单核细胞趋化蛋白-1是趋化因子CC亚家族的一员,在募集巨噬细胞等炎性细胞参与炎症反应中扮演着重要的角色.其趋化单核巨噬细胞于糖尿病肾组织中,可介导溶酶体释放,产生氧自由基,促进单核巨噬细胞表达β1-转化生长因子(transforming growth factor β1,TGF-β1),而广泛浸润臣噬细胞加剧了肾小球基底膜增厚、细胞外基质堆积,进而发展为肾小球硬化和间质纤维化.深入研究单核细胞趋化蛋白-1在糖尿病肾病中的作用,可望为糖尿病肾病的预防和治疗提供新的思路和途径.     

Differential expression of the isoforms for the monocyte chemoattractant protein-1 receptor, CCR2, in monocytes.

Two isoforms of human CCR2, the receptor for monocyte chemoattractant protein-1 (MCP-1), have been identified but their relative expression in monocytes and contribution to inflammatory responses mediated by MCP-1 remain uncertain. All available information on CCR2 expression is based on mRNA data because isoform-specific antibodies were not available until now. To analyze the relative expression of each isoform, we made two antibodies that specifically recognized CCR2A and CCR2B. Examination of receptor protein with these isoform-specific antibodies showed that the total expression of CCR2B in monocytes was about 10-fold higher than that of CCR2A with an equal distribution between the cell surface and intracellular pools. A detailed analysis using purified plasma membranes demonstrated that about 90% of all CCR2 on the cell surface were composed of CCR2B. The relatively abundant expression of CCR2B on the cell surface suggests a principal role of this isoform as a mediator of monocyte responses to MCP-1 in inflammation.     

2型糖尿病患者血清MCP-1与下肢大血管病变的相关性

目的:讨论2型糖尿病(T2DM)患者血清单核细胞趋化蛋白-1(monocyte chemoattractant protein-1;MCP-1)与下肢大血管病变的相关性。方法:(1)2型糖尿病患者61例,根据是否合并下肢大血管病变,分成无下肢大血管病变组(30例)、合并下肢大血管病变组(31例)与正常对照组(20例)对比,用双抗体夹心ELISA法测出血清MCP-1,比较组间血清MCP-1水平的异常。(2)测出各组甘油三酯、胆固醇、低密度脂蛋白、高密度脂蛋白、空腹血糖、糖化血红蛋白、纤维蛋白原等水平,分析各指标和2型糖尿病大血管病变的相关性。结果:(1)2型糖尿病组血清MCP-1水平明显高于正常对照组(P<0.05),合并下肢大血管病变组血清MCP-1水平明显高于无下肢大血管病变组和正常对照组(P<0.05),(2)以T2DM组为整体,有无下肢大血管病变为因变量Y(有=1,无=0),用MCP-1等其它危险因素为自变量,Logstic回归分析,病程、收缩压和MCP-1入回归方程。结论:MCP-1可能是T2DM下肢大血管病变的一个重要的独立危险因素。     

Lignin-derived lignophenols attenuate oxidative and inflammatory damage to the kidney in streptozotocin-induced diabetic rats

Abstract

This study investigated the effects of lignin-derived lignophenols (LPs) on the oxidative stress and infiltration of macrophages in the kidney of streptozotocin (STZ)-induced diabetic rats. The diabetic rats were divided into four groups with 0%, 0.11%, 0.33% and 1.0% LP diets. The vehicle-injected controls were given a commercial diet. At 5 weeks, superoxide (O₂^?) production, macrophage kinetics, the degree of fibrosis in glomeruli and mRNA expression for monocyte chemoattractant protein-1 (MCP-1) were examined. The NADPH-stimulated O₂^? levels in the kidney of the diabetic rats treated with 1.0% LP were significantly lower than those in untreated diabetic rats. The number of macrophages, levels of MCP-1 mRNA expression and degree of glomerular fibrosis increased in untreated LP and these levels were significantly lower in 1.0%LP-treated rats. The results suggested that LPs suppress the excess oxidative stress, the infiltration and activation of macrophages and the glomerular expansion in STZ-induced diabetic kidneys.